BioVenture Entrepreneurship Lab

A promising venture that hopes to develop a new drug therapy for colorectal cancer won $50,000 in funding and recognition from experienced venture capitalists on May 26 at the annual Biomedical Business Plan Challenge.

The inaugural Women at Weill investment competition recently selected Intellihealth, a comprehensive medical obesity treatment platform co-founded by Dr. Katherine Saunders, assistant professor of clinical medicine at Weill Cornell Medicine, as its first winner.

Dr. Jyotishman Pathak is a researcher who jokingly says that he’s “still learning to fake business” after launching a new company just six months ago. Though new to the business world, by any measure, he’s already a success.

The event, sponsored by the institution’s BioVenture eLab, is the culmination of a nine-week mentoring program that is designed to improve the ability of Weill Cornell Medicine clinicians and researchers to commercialize their concepts.

The second annual Dean’s Symposium on Opportunities for Entrepreneurship and Academic Drug Development highlighted the resources available to Weill Cornell Medicine investigators to help them turn their research findings into new treatments and therapies for patients.

The goal of the Dean’s Inaugural Symposium on Opportunities for Entrepreneurship and Academic Drug Development, hosted at Weill Cornell Medicine’s Uris Auditorium, was to highlight the resources available to investigators to help them turn their research findings into new treatments and therapies for patients.

As an undergraduate student, Du Cheng invented a laboratory camera adapter that would allow scientists to capture images with an iPhone and then view them through a microscope.

More Ph.D. students are pondering a wide range of careers — and the Weill Cornell Graduate School of Medical Sciences is helping them get there.